Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
drugs
life sciences
national blog main
3
×
national top stories
new york blog main
new york top stories
fda
san diego blog main
san diego top stories
akcea therapeutics
allopregnanolone
anylam pharmaceuticals
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
cancer
cardiomyopathy
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
entrectinib
express scripts
foundation medicine
indiana blog main
indiana top stories
inotersen
josh bilenker
keytruda
larotrectinib
loxo oncology
marc goodman
marinus pharmaceuticals
melanie nallicheri
merck
What
approved
3
×
drug
fda
oks
3
×
genetic
medicine
new
ago
akcea
alnylam
amyloidosis
attr
available
battle
brexanolone
cancer
debilitating
deeper
depression
devastating
disease
disorder
dna
fast
fingerprint
going
matter
medicines
moms
nd
partum
patients
pfizer
post
potentially
rare
relief
second
sets
specifically
Language
Current search:
" national blog main "
×
approved
×
oks
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues